Personalized nanovaccines for treating solid cancer metastases
Abstract Cancer vaccines have garnered attention as a potential treatment for cancer metastases. Nevertheless, the clinical response rate to vaccines remains < 30%. Nanoparticles stabilize vaccines and improve antigen recognition and presentation, resulting in high tumor penetration or accumulati...
Saved in:
| Main Authors: | Tang Feng, Jia Hu, Jirui Wen, Zhiyong Qian, Guowei Che, Qinghua Zhou, Lingling Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13045-024-01628-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revolutionizing Nanovaccines: A New Era of Immunization
by: Mohammed Saleh, et al.
Published: (2025-01-01) -
Can neutrophil/lymphocyte ratio be a predictor for bone metastases of solid tumors?
by: Billur Caliskan, et al.
Published: (2016-07-01) -
Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
by: Zhifan Zhang, et al.
Published: (2025-05-01) -
Emerging Cationic Nanovaccines
by: Ana Maria Carmona-Ribeiro, et al.
Published: (2024-10-01) -
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors
by: Zhang G, et al.
Published: (2025-06-01)